Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
23.83
+0.51 (2.19%)
Jun 12, 2026, 3:00 PM CST
SHA:600993 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:600993 stock has a consensus rating of "Strong Buy" and an average price target of ¥36.25. The average 1-year stock price forecast is 52.12% higher than the current stock price, while the lowest is ¥34.00 (+42.68%) and the highest is ¥38.50 (+61.56%).
Price Target: ¥36.25 (+52.12%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:600993 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jul '25 | Sep '25 | Oct '25 | Jan '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
4.32B
from 3.87B
Increased by 11.67%
Revenue Next Year
4.75B
from 4.32B
Increased by 10.10%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.3B | ||
| Avg | 4.3B | ||
| Low | 4.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.7% | ||
| Avg | 11.7% | ||
| Low | 11.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |